World Health Organization Sounds Concern Over Acute Lack of Weight-Loss Jabs
Fewer than a tenth of people who could benefit from obesity jabs including Wegovy are able to get them, caution the WHO as it releases its inaugural recommendations on the medications.
Considering over a billion people worldwide currently classified as obese, it is calling for increased and just availability to these injectable treatments.
Per estimates, over two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidelines recognises that obesity is a long-term condition that can be treated with comprehensive and ongoing support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and distribution challenges are major hurdles to broad access to the injections that can help people shift considerable body mass, notes the organization.
GLP-1 Therapy Scarcity
Even in the current most optimistic outlook, the manufacturing of these medications might only reach around 100 million people – less than 10% of those who need them, per the WHO.
The guideline calls on countries and companies to expand access, via approaches including patent sharing.
The intellectual property rights on the active ingredient – the core component of a leading brand – is set to lapse in multiple nations in 2026.
How Weight-Loss Drugs Function
The injections mimick a natural hormone to slow digestion, curb appetite and enhance the sense of being full so individuals consume fewer calories.
Individuals usually begin shedding pounds within a few weeks of commencing the regular doses.
Research indicates patients may put most of the weight back on a year later of stopping the drug, when their typical food cravings return.
To be above a healthy weight raises your risk for experiencing diseases, such as type 2 diabetes, cardiovascular issues, stroke, and specific malignancies.
Excess weight concerns individuals in all nations and was linked to 3.7 million fatalities worldwide in 2024, per the health agency.
